Venovenous extracorporeal membrane oxygenation in patients with COVID-19 respiratory failure

被引:8
作者
Hayanga, J. W. Awori [1 ,9 ]
Chatterjee, Subhasis [2 ,3 ]
Kim, Bo Soo [4 ]
Merritt-Genore, HelenMari [5 ]
Milewski, Rita Carrie Karianna [6 ]
Haft, Jonathan W. [7 ]
Arora, Rakesh C. [8 ]
机构
[1] West Virginia Univ Med, Dept Cardiothorac & Vasc Surg, Morgantown, WV USA
[2] Baylor Coll Med, Dept Surg, Div Gen, Houston, TX USA
[3] Baylor Coll Med, Dept Surg, Div Cardiothorac Surg, Houston, TX USA
[4] Johns Hopkins Med, Div Pulm & Crit Care Med, Baltimore, MD USA
[5] Methodist Phys Clin, Omaha, NE USA
[6] Yale Sch Med, Dept Cardiac Surg, New Haven, CT USA
[7] Univ Michigan, Michigan Med, Dept Cardiac Surg, Ann Arbor, MI USA
[8] Univ Manitoba, Max Rady Coll Med, Dept Surg, Sect Cardiac Surg, Winnipeg, MB, Canada
[9] West Virginia Univ, Dept Cardiovasc & Thorac Surg, 1 Med Ctr Dr, Morgantown, WV 26506 USA
关键词
extracorporeal membrane oxygenation; COVID-19; adult respiratory distress syndrome; DISTRESS-SYNDROME; SUPPORT; OUTCOMES;
D O I
10.1016/j.jtcvs.2021.09.059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The high level of human-to-human transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the severity of coronavirus disease 2019 (COVID-19) have perpetuated an international public health emergency. Indeed, this pandemic has evolved into the greatest health challenge of the 21st century. Virus entry is mediated by the structural spike membrane protein, which plays a significant role in host cell receptor recogni-tion and membrane fusion. Angiotensin-converting enzyme 2 serves as the functional culprit host cell receptor.1 The COVID-19 pandemic has tested the resilience of the global health infrastructure and unleashed a slew of novel stra-tegies and technological advances in the armamentarium against this viral threat. Like the experience with influenza pandemic of the early 2000s, extracorporeal support has served as a rescue option favored in the face of failing conventional therapy. The clinical experience with extracorporeal mem-brane oxygenation (ECMO) thus far has been framed through the lens of single-center, nonrandomized reports that vary in both methodology and outcomes.2-5 Severity of disease may be estimated using the World Health Organization classification system, which assigns a grade from 1 to 9 in order of increasing severity.6 There is not yet a consensus ECMO-specific scoring system, and to this end, the Murray, PRESERVE,4 and RESP5 scores each remain applicable in the quantification of severity in this cohort, although not neces-sarily specific to COVID-19 or its prognosis.
引用
收藏
页码:212 / 217
页数:6
相关论文
共 44 条
[1]   A Dual-Lumen Percutaneous Cannula for Managing Refractory Right Ventricular Failure [J].
Badu, Bernice ;
Cain, Michael T. ;
Durham, Lucian A. ;
Joyce, Lyle D. ;
Sundararajan, Sakthi ;
Gaglianello, Nunzio ;
Ishizawar, David ;
Saltzberg, Mitchell ;
Mohammed, Asim ;
Joyce, David L. .
ASAIO JOURNAL, 2020, 66 (08) :915-921
[2]   Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization [J].
Badulak, Jenelle ;
Antonini, M. Velia ;
Stead, Christine M. ;
Shekerdemian, Lara ;
Raman, Lakshmi ;
Paden, Matthew L. ;
Agerstrand, Cara ;
Bartlett, Robert H. ;
Barrett, Nicholas ;
Combes, Alain ;
Lorusso, Roberto ;
Mueller, Thomas ;
Ogino, Mark T. ;
Peek, Giles ;
Pellegrino, Vincent ;
Rabie, Ahmed A. ;
Salazar, Leonardo ;
Schmidt, Matthieu ;
Shekar, Kiran ;
MacLaren, Graeme ;
Brodie, Daniel .
ASAIO JOURNAL, 2021, 67 (05) :485-495
[3]   Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry [J].
Barbaro, Ryan P. ;
MacLaren, Graeme ;
Boonstra, Philip S. ;
Iwashyna, Theodore J. ;
Slutsky, Arthur S. ;
Fan, Eddy ;
Bartlett, Robert H. ;
Tonna, Joseph E. ;
Hyslop, Robert ;
Fanning, Jeffrey J. ;
Rycus, Peter T. ;
Hyer, Steve J. ;
Anders, Marc M. ;
Agerstrand, Cara L. ;
Hryniewicz, Katarzyna ;
Diaz, Rodrigo ;
Lorusso, Roberto ;
Combes, Alain ;
Brodie, Daniel .
LANCET, 2020, 396 (10257) :1071-1078
[4]  
Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]
[5]   COVID-19: Regulatory Landscape of Medicinal and Medical Device Products for Human Use [J].
Beninger, Paul .
CLINICAL THERAPEUTICS, 2020, 42 (08) :1444-1450
[6]   A comparison study of haemolysis production in three contemporary centrifugal pumps [J].
Bottrell, S. ;
Bennett, M. ;
Augustin, S. ;
Thuys, C. ;
Schultz, B. ;
Horton, A. ;
Horton, S. .
PERFUSION-UK, 2014, 29 (05) :411-416
[7]   Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines [J].
Bryant, Andrew ;
Lawrie, Theresa A. ;
Dowswell, Therese ;
Fordham, Edmund J. ;
Mitchell, Scott ;
Hill, Sarah R. ;
Tham, Tony C. .
AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (04) :E434-E460
[8]   Cardiac surgery during the COVID-19 sine wave: Preparation once, preparation twice. The view from Houston [J].
Chatterjee, Subhasis ;
Anton, James M. ;
Rosengart, Todd K. ;
Coselli, Joseph S. .
JOURNAL OF CARDIAC SURGERY, 2021, 36 (05) :1615-1623
[9]   Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome [J].
Combes, A. ;
Hajage, D. ;
Capellier, G. ;
Demoule, A. ;
Lavoue, S. ;
Guervilly, C. ;
Da Silva, D. ;
Zafrani, L. ;
Tirot, P. ;
Veber, B. ;
Maury, E. ;
Levy, B. ;
Cohen, Y. ;
Richard, C. ;
Kalfon, P. ;
Bouadma, L. ;
Mehdaoui, H. ;
Beduneau, G. ;
Lebreton, G. ;
Brochard, L. ;
Ferguson, N. D. ;
Fan, E. ;
Slutsky, A. S. ;
Brodie, D. ;
Mercat, A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (21) :1965-1975
[10]   ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities [J].
Cuervo, Natalia Zamorano ;
Grandvaux, Nathalie .
ELIFE, 2020, 9